Literature DB >> 16833034

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

D Guidetti1, B Casali, R L Mazzei, M T Dotti.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an inherited autosomal dominant condition characterized by migrane, recurrent stroke, subcortical dementia, and pseudobulbar palsy. It begins with migraine with aura in -33% of patients. CADASIL is commonly overlooked or misdiagnosed owing to its recent identification. The pathological hallmark of angiopathy is the presence of multiple, small, deep cerebral infarcts, leucoencephalopathy, and nonatherorosclerotic, nonamyloid angiopathy involving mainly small, deep perforating cerebral arteries. Changes also are present in vascular smooth muscle cells and consist in the presence of granular osmiophilic material (GOM). The defective gene in CADASIL is Notch 3, which encodes a large transmembrane receptor. Magnetic resonance imaging shows high intensity signal lesions, often confluent, and areas of cystic degeneration of subcortical white matter and basal ganglia. Diagnostic strategies in CADASIL are matter of discussions because the electron microscopic demonstration of GOM was reported in 100% of symptomatic patients of French authors, but only in 45% of a British study. GOMs are not present in presymptomatic patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16833034     DOI: 10.1080/10641960600549223

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  3 in total

1.  Genetics of Vascular Dementia.

Authors:  Melissa E Murray; James F Meschia; Dennis W Dickson; Owen A Ross
Journal:  Minerva Psichiatr       Date:  2010-03

2.  Single gene disorders associated with stroke: a review and update on treatment options.

Authors:  Hurmina Muqtadar; Fernando D Testai
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-06

3.  NOTCH3 variants and risk of ischemic stroke.

Authors:  Owen A Ross; Alexandra I Soto-Ortolaza; Michael G Heckman; Christophe Verbeeck; Daniel J Serie; Sruti Rayaprolu; Stephen S Rich; Michael A Nalls; Andrew Singleton; Rita Guerreiro; Emma Kinsella; Zbigniew K Wszolek; Thomas G Brott; Robert D Brown; Bradford B Worrall; James F Meschia
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.